Heart attacks and strokes are among the leading causes of death globally, with millions suffering from cardiovascular diseases (CVD) every year. There are more than seven million people in the UK alone, with about 100,000 patients experiencing heart attacks annually. However, a group of researchers at University College London (UCL) estimate that one 'polypill' taken daily day could eliminate a majority of these cases dramatically lowering death tolls.

The proposed polypill, a combination of a statin and three blood pressure-lowering drugs, has been under study for over two decades. Experts argue that introducing this pill universally for individuals aged 50 and above could be more effective than the current NHS Health Check, which assesses risk factors every five years for those aged between 40 and 74.

Studies have repeatedly proven the effectiveness of the polypill in preventing CVD. A groundbreaking 2019 study in The Lancet found that five years' use of the polypill cut the risk of heart attack and stroke by a third. In addition, previous modelling analyses have estimated that if given universally to people over 55, the polypill might be able to prevent 80% of heart attacks and strokes.

Today, the NHS Health Check follows a risk-based model in which patients are tested for CVD risk factors and treated with drugs accordingly. Yet, as per UCL's study, this system has serious flaws:

Low Uptake: Just 40% of those eligible for the NHS Health Check choose to have it, leaving a considerable number of at-risk patients undiagnosed and untreated.

Ineffective Prediction of Risk: The majority of heart attacks and strokes happen to people at average risk levels, thus making it challenging to identify the need for intervention effectively.

Limited Effectiveness: Even at maximum take-up, the NHS Health Check programme is predicted to have fewer health impacts compared to a polypill initiative applied to the whole population.

Simplicity and Affordability of the Polypill Strategy

One of the big benefits of the polypill is that it is so easy. In contrast to the existing screening-based model, the polypill scheme would not involve complicated medical tests or lengthy risk assessments. Instead, people reaching 50 would just have to fill out a few questions to determine possible side effects before they were prescribed.

Professor Aroon Hingorani of the UCL Institute of Cardiovascular Science, one of the strongest proponents of this scheme, says:

"Finally, the time is now to do much better on prevention. A population approach would prevent a lot more heart attacks and strokes than is done today with a strategy of trying to target a smaller group only."

Aside from the possible health implications, the polypill is also an economic solution. The drugs used are off-patent, thus cheap to produce and distribute. With the vast economic cost of managing CVD-related illnesses, a preventive model could result in substantial cost-saving for the NHS in the future.

The polypill has been proven to be effective by numerous international trials. In 2019, a randomised trial in rural Iran discovered that participants who took the polypill for five years had a 34% reduced risk of having a heart attack or stroke compared to non-participants.

Likewise, modelling research has indicated that even if only 8% of people aged over 50 took up the polypill regimen, it would still be more beneficial to their health than the NHS Health Check programme.

Is This a Case of Over-Medicalisation?

One of the main objections to the polypill strategy is the suggestion that it might result in the unnecessary medicalisation of a significant proportion of the population. But, it is argued, it should be considered as a preventative measure, not as mass medication.

Professor Sir Nicholas Wald of UCL's Institute of Health Informatics explains:

"Instead of being a 'medicalisation' of a significant proportion of the population, a polypill programme is a prevention measure to prevent an individual from becoming a patient."

He compares it with public health measures like water fluoridation or compulsory seatbelts—interventions that have been shown to have a significant impact in reducing public health danger at low individual cost.

With the evidence in favour of the polypill's effectiveness and viability overwhelming, experts are calling on the NHS to act now. It is their belief that substituting the NHS Health Check with a polypill-based prevention program could be the UK government's flagship policy under its pledge to put disease prevention ahead of cure.

As Professor Hingorani points out, "The status quo is not a justifiable option." With CVD still a major cause of death globally, taking a population-wide polypill approach could be a turning point for preventative medicine, potentially saving thousands of lives annually. The question now is whether the NHS will take up this call and establish a policy with the potential to transform the prevention of cardiovascular disease on a national level.

A resident of New York has tested positive for the chikungunya virus, marking the first local transmission of the mosquito-borne illness in the United States in six years, according to state health officials. The New York State Department of Health confirmed Tuesday that the case was detected in a person from Nassau County, Long Island.

The county’s health department stated that the individual began showing symptoms in August after traveling outside the region but not leaving the country. Officials have not disclosed the person’s identity or the exact source of infection.

What Is Chikungunya?

Chikungunya (CHIKV) is a viral disease spread to humans through the bites of infected mosquitoes, primarily Aedes aegypti and Aedes albopictus. Infection occurs when a mosquito carrying the virus bites a person. It does not spread from one person to another through touch, saliva, or airborne particles, although transmission through blood is possible in rare cases.

The illness is known for causing high fever and severe joint pain, often intense enough to affect mobility. The name “chikungunya” originates from a word meaning “that which bends up,” describing the stooped posture people often develop due to the pain. There is currently no antiviral treatment for the infection, and care mainly focuses on relieving symptoms. Most individuals recover within a week, though some experience lingering joint discomfort for weeks or months.

What Are The Symptoms Of Chikungunya?

Symptoms typically appear three to seven days after an infected mosquito bite, though in some cases they can develop as early as two days or as late as 12. The most common symptoms are fever and joint pain, which may be mild for some but extremely painful for others. The fever often starts suddenly, and some people mistake their symptoms for another illness or may not seek medical attention.

Other signs of chikungunya include:

• Headache
• Muscle aches
• Joint swelling
• Rash
• Fatigue
• Nausea

Is Chikungunya Contagious?

The virus spreads only through the bite of an infected mosquito. A person with chikungunya cannot pass the virus directly to another person through saliva, touch, or respiratory droplets. The risk of transmission to another mosquito is highest during the first week of symptoms, when the virus is present in the blood.

While New York has recorded three other cases of chikungunya earlier this year, all were linked to international travel. Local mosquitoes, however, are capable of carrying and spreading other viruses such as West Nile, Eastern Equine Encephalitis, and Jamestown Canyon virus.

Times Now Network conducted a survey where different hospital chains were ranked to understand how well the hospitals and healthcare institutions in India work and if the services offered by them adhere to the benchmarks given by NABH, under the Quality council of India.

The parameters on which these hospitals were judged were VFM or value for money, quality of treatment, team of consultants and doctors, infrastructure, hygiene and cleanliness, faculties and public convenience, and innovation and research facilities. The factual scores were submitted by the institutions and held 60% weightage, while the perceptual scores held a weightage of 40% weightage.

The institutes were asked to submit details and information including verification and validation by a research agency. The scores were also based on the perceptual survey, with a sample size of 3000, conducted across 16 cities, and then the final scores were calculated based on the weightages of the different parameters. Word of mouth is also considered in the survey as it holds a critical point in decision making. The results were announced in the latest India Health Summit, held at Taj Palace, Delhi on October 4, 2025.

The Ranks Are As Followed

The survey covered various critical care specialties, including cardiology, neurology, nephrology, oncology, obstetrics and gynecology, pediatrics, urology, gastroenterology, and emergency and trauma. Among the lifestyle categories were dental health, orthopedics, diabetes care, IVF & fertility, and cosmetic and plastic surgery.

The sample size was across 12 cities, which included 3300 doctors and patients with the ratio of 40:60. It was as followed:

• Delhi NCR had a sample size of 300
• Mumbai had a sample size of 300
• Chennai had a sample size of 300
• Kolkata had a sample size of 300
• Bengaluru had a sample size of 300
• Hyderabad had a sample size of 300
• Ahmedabad had a sample size of 250
• Pune had a sample size of 250
• Bhubaneswar had a sample size of 250
• Jaipur had a sample size of 250
• Lucknow had a sample size of 250
• Kochi had a sample size of 250

In addition to this, for Factual Survey, over 1500 hospitals across India were targeted and connected.

The main objective of this survey was to provide clarity that usually lacks in other ranking as they do not detail out on how the hospitals is performing better than others and on what parameters and hence it is difficult for patients to take an informed decision.

"My brain seems to be sorta lowkey rebelling against me," says the General Hospital star Kristen Storms who revealed that she will soon be undergoing a surgery to treat her brain aneurysm.

The 41-year-old ABC soap opera star on October 14 shared her healthy journey in a candid Instagram post, revealing that she had discovered about her condition in a recent medical scan.

A New Discovery During A Typical Scan

She explained that while doing a follow-up scan for the cyst she had removed from her brain in 2021, she discovered aneurysm on the right side. “While undergoing a follow-up scan for the cyst, my neurosurgeon discovered an aneurysm on the right side,” she wrote.

In January, she underwent a procedure in which doctors threaded a tiny camera from her leg up to her brain, a process she humorously described as “insane.” “It’s a routine procedure, but the path inside your body that they lead the camera through is wild,” she said. “THE CAMERA GOES THROUGH YOUR ARMPIT, guys. Your. Armpit.”

However, due to the complexity of her case, the doctors did not perform the surgery.

What Is Coiling? How Does It Treat Brain Aneurysm?

A brain aneurysm is a weak, bulging area on the wall of a blood vessel in the brain that can resemble a balloon or blister. Most brain aneurysms cause no symptoms until they rupture, which can lead to a life-threatening hemorrhage (bleeding) called a subarachnoid hemorrhage (SAH). Rupture can result in stroke, brain damage, coma, or death, making a ruptured aneurysm a medical emergency that requires immediate treatment.

According to Johns Hopkins Medicine, coiling is a minimally invasive procedure used to block blood flow to an aneurysm. By placing soft platinum coils, which are thinner than a strand of hair, into the bulging artery, doctors can prevent it from rupturing. If left untreated, a burst aneurysm can lead to brain damage or even be fatal.

Storms shared that her coiling procedure is now being scheduled within the next two weeks. To calm her nerves while she waits, she’s been spending time with her close friend and former co-star Emme Rylan (who played Lulu on General Hospital), “crocheting the most beautiful sweaters,” as she put it.

A Life Changing Moment

"Aneurysms (obviously) can be caused by stress. It was clear I needed to change some things in my life asap. For my own personal reasons, no longer living in Los Angeles was very important to me. The biggest reason was Harper, but also for my physical and mental health. And my overall happiness," she wrote.

Earlier this year, Storms took a break from General Hospital and relocated to Nashville with her 11-year-old daughter, Harper.

In her post she also addressed false rumor around her hospital visits when someone had spread a rumor that Storms was hospitalized for a suicide attempt. "I couldn’t understand why a person would make up something that terrible when they had no idea why I was really there,” she said.

However, despite all this, she keeps a positive and a hopeful attitude, which also showed in her message that read: “There are a few really bad apples out there. But there are people in my life who I am truly thankful to know. One of those individuals just made a sh*t load of sweaters with me. They are glorious.”

She ended the note with: "“Even though my brain seems to be sorta lowkey rebelling against me, we’ve all got times when things aren’t great. If we can, we’ll do our best for ourselves and our loved ones.”